Atrial fibrillation and thromboembolic risk: What is the extent of adherence to guidelines in clinical practice?;Fibrilhação auricular e risco tromboembólico: Que aderêneia às recomendações na prática clínica? [12]

Revista Portuguesa de Cardiologia

Volumn 30, Issue 2, 2011, Pages 171-180

  Dores, Hélder Alexandre Correia ^a,b   Cardiga, Rosa ^a,b   Ferreira, Ricardo ^a,b   Araújo, Inês ^a,b   Gândara, Filipa ^a,b   Abreu, Ana ^a,b   Marques, Filipa ^a,b   Leitao, Ana ^a,b   Fonseca, Cândida ^a,b   Ceia, Fátima ^a,b  

^a HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

Author keywords

Atrial fibrillation; Guidelines; Oral anti coagulation; Thromboembolic risk

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; COMORBIDITY; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION;

AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; THROMBOEMBOLISM;

EID: 79955454676     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wattigney W, Mensah G, Croft J. Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention. Circulation 2003; 108: 711-16.
2. Gto AS, Hylek EM, Phillips Ka, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 2001; 285:2370-75. (Pubitemid 32424106)
3. Fuster V, Rydén L, Cannom D, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: full text. Europace 2006; 8:651-745.
4. Wolf A, Abbott D, Kannel B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22:983-8.
5. Serrano M, Hernandez M. Atrial Fibrillation: Is it epidemic? Rev Esp Cardiol 2009; 62:10-4.
6. Hart R, Pearce L, Aguilar M. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67. (Pubitemid 351650486)
7. Walraven C, Hart R, Connolly S, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation. Stroke 2009; 40:00-00.
8. Hart RG, Pearce LA, Halperin JL, et al. Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation. Stroke 2008; 39:1901-10.
9. Zehnder S, Schaer A, Jeker U, Cron A, Osswald S. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines. Swiss Med Wkly 2006; 136:757-60. (Pubitemid 46121627)
10. McBride D, Bruggenjurgen, Roll S, Willich S. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis 2007; 24:65-72. (Pubitemid 46838499)
11. Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Eur Heart J 2006; 27:1954-64.
12. Hylek E, D'Antonio J, Molina C et al. Translating the results of randomized trials into clinical practice. Stroke 2006; 37:1075.
13. Gladstone D, Bui E, Fang J et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009; 40:235.